JENNIFER ARAKAKI: Open Payments
NPI 1669185104 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 15 payments from 10 companies in 2025. Trend: 2023 $87 · 2024 $893 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $81 |
| Incyte Corporation | 3 | $61 |
| ABBVIE INC. | 2 | $60 |
| STRATA Skin Sciences, Inc. | 2 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $34 |
| Boston Scientific Corporation | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $23 |
| LNHC, Inc | 1 | $18 |
| Organon LLC | 1 | $13 |
Products named: DUPIXENT, OPZELURA, XTRAC, WaveWriter Alpha Prime 16, RINVOQ, SKYRIZI, OTEZLA, ZELSUVMI.
Industry payments across CA — which companies pay providers there.
